PharmaCo needed a new clinical development sourcing strategy Create a comprehensive picture of the clinical outsourcing market Build a framework for outsourcing decision-making PharmaCo is able to focus R&D resources on drug discovery and innovation Clinical outsourcing strategy Problem: Facing a challenging market environment, PharmaCo needed a new clinical development sourcing strategy that would allow it to address its growing pipeline under existing budget constraints. PharmaCo, a top-5 pharmaceutical company, was historically extremely conservative with its sourcing of clinical trials, outsourcing less than 10% of its clinical budget and keeping all complicated tasks in-house PharmaCo's existing sourcing strategy was unable to meet the demands of its pipeline given budget constraints and challenges to the pharmaceutical industry Under PharmaCo's existing strategy, it was missing the opportunity to use clinical sourcing to help it overcome challenges to its business: The clinical outsourcing industry was maturing, with the largest outsourcing companies performing more trials than the largest pharmaceutical companies The supply of clinical resources (patients and investigators) was decreasing Trials were increasingly moving to low-cost, high-recruitment regions PharmaCo was also failing to take advantage of innovative, strategic sourcing relationships in which other pharmaceutical companies were beginning to enter Bain was asked to assess the clinical outsourcing landscape and recommend to PharmaCo a new clinical sourcing strategy that captured what, why, how, and to whom it should outsource